Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BLRX |
---|---|---|
09:32 ET | 1330 | 0.6028 |
09:41 ET | 1100 | 0.6098 |
10:17 ET | 1087 | 0.61 |
10:21 ET | 200 | 0.6172 |
10:30 ET | 3700 | 0.6147 |
10:32 ET | 568 | 0.6124 |
10:33 ET | 300 | 0.6147 |
10:37 ET | 200 | 0.6147 |
10:42 ET | 600 | 0.6118 |
10:46 ET | 2400 | 0.6101 |
10:48 ET | 3900 | 0.61 |
10:50 ET | 4211 | 0.6135 |
10:55 ET | 16695 | 0.6033 |
11:02 ET | 11815 | 0.602 |
11:09 ET | 11279 | 0.6 |
11:13 ET | 200 | 0.6062 |
11:22 ET | 3000 | 0.6055 |
11:24 ET | 27350 | 0.6062 |
11:44 ET | 3900 | 0.6031 |
11:45 ET | 600 | 0.6032 |
11:47 ET | 900 | 0.6016 |
12:02 ET | 1000 | 0.6032 |
12:03 ET | 500 | 0.6032 |
12:25 ET | 3000 | 0.6135 |
12:27 ET | 1000 | 0.6135 |
12:30 ET | 2128 | 0.613399 |
12:34 ET | 1000 | 0.607499 |
12:38 ET | 3801 | 0.607499 |
12:39 ET | 3876 | 0.6135 |
12:54 ET | 5628 | 0.6075 |
12:56 ET | 2200 | 0.6075 |
12:57 ET | 1100 | 0.6075 |
01:01 ET | 1100 | 0.6075 |
01:06 ET | 1100 | 0.6075 |
01:15 ET | 100 | 0.6135 |
01:19 ET | 158 | 0.6135 |
01:32 ET | 100 | 0.6135 |
01:48 ET | 4361 | 0.6135 |
02:00 ET | 1000 | 0.6134 |
02:02 ET | 300 | 0.6075 |
02:04 ET | 3000 | 0.607499 |
02:06 ET | 8073 | 0.6135 |
02:27 ET | 500 | 0.6199 |
02:31 ET | 500 | 0.6187 |
02:33 ET | 1900 | 0.618501 |
02:36 ET | 500 | 0.6199 |
02:38 ET | 1500 | 0.62 |
02:40 ET | 1900 | 0.614999 |
02:42 ET | 6443 | 0.6224 |
02:44 ET | 3900 | 0.6299 |
02:49 ET | 2200 | 0.61 |
02:56 ET | 2100 | 0.62 |
03:02 ET | 200 | 0.62 |
03:12 ET | 664 | 0.62 |
03:14 ET | 200 | 0.6201 |
03:18 ET | 4700 | 0.6298 |
03:20 ET | 100 | 0.6201 |
03:30 ET | 100 | 0.6299 |
03:48 ET | 400 | 0.6102 |
03:52 ET | 700 | 0.62 |
03:56 ET | 3900 | 0.6104 |
03:59 ET | 763 | 0.62 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
BioLine RX Ltd | 51.4M | -0.7x | --- |
Dyadic International Inc | 53.8M | -6.8x | --- |
Kronos Bio Inc | 60.1M | -0.5x | --- |
Palatin Technologies Inc | 32.9M | -0.9x | --- |
Kezar Life Sciences Inc | 56.2M | -0.5x | --- |
Evogene Ltd | 37.4M | -1.4x | --- |
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $51.4M |
---|---|
Revenue (TTM) | $4.8M |
Shares Outstanding | 79.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.49 |
EPS | $-0.95 |
Book Value | $0.18 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | 10.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,035.29% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.